China Insulin Patch Pumps Market Size & Outlook, 2023-2030
- MedTech
- Diabetes Care
- Insulin Patch Pumps Market Outlook
- Diabetes Care
China Insulin Patch Pumps Market, 2018-2030 (US$M)
Global Market
Related Markets
Ask Prism AI about the insulin patch pumps market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
China insulin patch pumps market highlights
- The China insulin patch pumps market generated a revenue of USD 34.5 million in 2023 and is expected to reach USD 78.0 million by 2030.
- The China market is expected to grow at a CAGR of 12.3% from 2024 to 2030.
- In terms of segment, basal and bolus was the largest revenue generating delviery mode in 2023.
- Basal and Bolus is the most lucrative delviery mode segment registering the fastest growth during the forecast period.
Insulin patch pumps market data book summary
| Market revenue in 2023 | USD 34.5 million |
| Market revenue in 2030 | USD 78.0 million |
| Growth rate | 12.3% (CAGR from 2023 to 2030) |
| Largest segment | Basal and bolus |
| Fastest growing segment | Basal and Bolus |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Basal, Bolus, Basal and Bolus |
| Key market players worldwide | Medtronic PLC, Roche Holding AG, Insulet Corp, Terumo Corp, Tandem Diabetes Care Inc, CeQur Simplicity, Medtrum, Debiotech |
Other key industry trends
- In terms of revenue, China accounted for 3.5% of the global insulin patch pumps market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China insulin patch pumps market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 77.8 million by 2030.
According to the International Diabetes Federation, more than 116 million people in China were living with diabetes in 2019, and this number is expected to reach 140 million by 2030. China held the largest diabetic population in the world, at a prevalence of 10.9%.
With the ongoing economic development in the country, the cost of diabetes per person has increased, from USD 115.0 in 2010 to USD 936.2 in 2019. A majority of China’s diabetic population depends heavily on insulin.
Players in China hold major untapped opportunities in the insulin pump market. More than 54 million in China suffer from impaired glucose tolerance. However, the use of insulin pumps by diabetic patients is uncommon in the country.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Insulin Patch Pumps Market Scope
Insulin Patch Pumps Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Medtronic PLC | View profile | 95,000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | www.medtronic.com |
| Roche Holding AG | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Insulet Corp | View profile | 3,000 | 100 Nagog Park, Acton, MA, United States, 01720 | www.insulet.com |
| Terumo Corp | View profile | 30,207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | www.terumo.com |
| Tandem Diabetes Care Inc | View profile | 2,400 | 12400 High Bluff Drive, San Diego, CA, United States, 92130 | www.tandemdiabetes.com |
| CeQur Simplicity | View profile | 51-100 | Horw, Luzern, Switzerland, Europe | myceqursimplicity.com |
| Medtrum | View profile | 101-250 | Shanghai, Shanghai, China, Asia | medtrum.com/ |
| Debiotech | View profile | 11-50 | Lausanne, Vaud, Switzerland, Europe | www.debiotech.com |
China Insulin Patch Pumps Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Insulin Patch Pumps Market Outlook will help companies and investors design strategic landscapes.
Basal And Bolus was the largest segment with a revenue share of 56.52% in 2023.
Horizon Databook has segmented the China insulin patch pumps market based on basal, bolus, basal and bolus covering the revenue growth of each sub-segment from 2018 to 2030.
According to the International Diabetes Federation, more than 116 million people in China were living with diabetes in 2019, and this number is expected to reach 140 million by 2030. China held the largest diabetic population in the world, at a prevalence of 10.9%.
With the ongoing economic development in the country, the cost of diabetes per person has increased, from USD 115.0 in 2010 to USD 936.2 in 2019. A majority of China’s diabetic population depends heavily on insulin.
Players in China hold major untapped opportunities in the insulin pump market. More than 54 million in China suffer from impaired glucose tolerance. However, the use of insulin pumps by diabetic patients is uncommon in the country.
- China Insulin Patch Pumps Market Delviery Mode Outlook (Revenue, USD Million , 2018-2030)
- Basal
- Bolus
- Basal and Bolus
- China Insulin Patch Pumps Market Type Outlook (Revenue, USD Million , 2018-2030)
- Disposable
- Reusable
- China Insulin Patch Pumps Market Distribution Channel Outlook (Revenue, USD Million , 2018-2030)
- Hospitals
- Retail Pharmacies
- Private Clinics
- Online Pharmacies
- Others
Reasons to subscribe to Insulin Patch Pumps Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Insulin Patch Pumps Market Outlook databook
- Our clientele includes a mix of Insulin Patch Pumps Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China Insulin Patch Pumps Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China Insulin Patch Pumps Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
China Insulin Patch Pumps Market, 2018-2030 (US$M)
China insulin patch pumps market statistics, by delviery mode, 2018-2030 (US$M)
